Showing 3921-3930 of 9118 results for "".
- Online Team-Based Care Matches In-Person Outcomes for Atopic Dermatitis: Analysishttps://practicaldermatology.com/news/online-team-based-care-matches-in-person-outcomes-for-atopic-dermatitis-analysis/2487582/A team-based connected health (TCH) model delivered online achieved equivalent improvements in atopic dermatitis (AD) severity compared with traditional in-person care, according to results from a randomized clinical trial. T
- Skin of Color Still Underrepresented Across Major Dermatology Image Searcheshttps://practicaldermatology.com/news/skin-of-color-still-underrepresented-across-major-dermatology-image-searches/2487573/Skin of Color (SOC) remains significantly underrepresented in image search results across major search engines, according to a recent Letter to the Editor published in the Journal of Drugs in Dermatology. Investigators building on earlier research in the area evaluated the first 5
- Global Integral Beauty Conference Marks Fifth Anniversary With Expanded International Programhttps://practicaldermatology.com/news/global-integral-beauty-conference-marks-fifth-anniversary-with-expanded-international-program/2487545/Global Integral Beauty (GIB) has announced that its 5th Global Integral Beauty Conference will be held on October 17, 2026, at the New York Marriott Marquis in New York, New York. Now entering its fifth year, the conference s
- Paroxetine Linked to Neurovascular and Immune Proteomic Changes in Refractory Rosacea: Analysishttps://practicaldermatology.com/news/paroxetine-linked-to-neurovascular-and-immune-proteomic-changes-in-refractory-rosacea/2487517/A secondary analysis of a randomized clinical trial in JAMA Dermatology identified systemic proteomic changes associated with paroxetine treatment in patients with refractory erythematous rosacea, offering new insight into
- Analysis Shows Long-Term Cost Impact of Psoriasis and Psoriatic Arthritishttps://practicaldermatology.com/news/analysis-highlights-long-term-cost-impact-of-psoriasis-and-psoriatic-arthritis/2487486/New research published in Dermatology and Therapy suggests the economic burden associated with psoriasis and psoriatic arthritis extends far beyond the diseases themselves and may reach hundreds of billions of dollars over a lifetime. Psoriatic Disease Comorbidities Drive Signifi
- FDA Expands Dupilumab CSU Indication to Children as Young as 2 Yearshttps://practicaldermatology.com/news/dupilumab-approval-expanded-to-include-children-as-young-as-2-years-with-csu/2487479/The US Food and Drug Administration (FDA) has expanded the indication for dupilumab (Dupixent; Sanofi and Regeneron) to include pediatric patients aged 2 to 11 years with chronic spontaneous urticaria (CSU) who remain symptomatic despite H1 antihistamine treatment. The label expansion, according
- Comparative Study Finds No Significant Melanoma Mortality Reduction From German Screening Initiativehttps://practicaldermatology.com/news/comparative-study-finds-no-significant-melanoma-mortality-reduction-from-german-screening-initiative/2487471/A study of a German nationwide skin cancer screening (SCS) program showed reduced melanoma mortality compared with neighboring European countries that do not have population-based screening programs. Germany launched its nationwide SCS program in 2008, which included adults aged 35 years a
- Study Links Childhood Adversity to Mitochondrial Changes and Atopic Dermatitis Riskhttps://practicaldermatology.com/news/study-links-childhood-adversity-to-mitochondrial-changes-and-atopic-dermatitis-risk/2487465/A new study published in Psychoneuroendocrinology suggests that adverse childhood experiences (ACEs) may contribute to biologic changes associated with atopic disease, identifying mitochondrial DNA copy number (mtDNAcn) as a
- Oral Nicotinamide Linked to Fewer Skin Cancers and Lower Treatment Costshttps://practicaldermatology.com/news/oral-nicotinamide-linked-to-fewer-skin-cancers-and-lower-treatment-costs/2487444/Oral nicotinamide may offer a cost-effective strategy for preventing keratinocyte carcinoma (KC) in patients at high risk for developing multiple skin cancers, according to a new economic evaluation conducted within the Veterans Health Administration (VHA) published in JAMA Dermatology.<
- Maternal Type 2 Diabetes Not Linked to Reduced AD Risk in Children: Studyhttps://practicaldermatology.com/news/maternal-type-2-diabetes-not-linked-to-reduced-ad-risk-in-children-study/2487400/New research suggests maternal type 2 diabetes mellitus (T2DM) does not independently influence the risk of atopic dermatitis (AD) in children. Researchers for a retrospective cohort study analyzed electronic medical and birth records from Clalit Health Services in Israel (n = 314,224 moth